OMRNY(OMRNY)
OMRNY
No analyst ratings available
No analyst price targets available for OMRNY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $869.08B | $928.86B | $969.98B | $977.95B | $1.02T |
| Low | $857.45B | $911.43B | $954.30B | $962.15B | $1.00T |
| High | $911.38B | $992.77B | $1.03T | $1.04T | $1.08T |
| EBITDA Avg | $105.67B | $112.94B | $117.94B | $118.91B | $123.82B |
| Low | $104.26B | $110.82B | $116.04B | $116.99B | $121.82B |
| High | $110.82B | $120.71B | $124.91B | $125.94B | $131.13B |
| EBIT Avg | $73.63B | $78.70B | $82.18B | $82.85B | $86.27B |
| Low | $72.65B | $77.22B | $80.85B | $81.52B | $84.88B |
| High | $77.22B | $84.11B | $87.03B | $87.75B | $91.37B |
| Net Income Avg | $40.45B | $61.36B | $68.16B | $58.91B | $67.90B |
| Low | $39.60B | $60.07B | $66.73B | $57.67B | $66.47B |
| High | $43.56B | $66.07B | $73.39B | $63.43B | $73.11B |
| EPS Avg | $205.61 | $311.87 | $346.45 | $299.43 | $345.10 |
| Low | $201.29 | $305.32 | $339.17 | $293.14 | $337.86 |
| High | $221.39 | $335.82 | $373.05 | $322.42 | $371.60 |
| Analysts (Rev / EPS) | 10 / 1 | 11 / 1 | 6 / 1 | 7 / 1 | 7 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $205.10B | $215.13B | $251.03B |
| Low | $205.10B | $215.13B | $251.03B |
| High | $205.10B | $215.13B | $251.03B |
| EBITDA Avg | $24.94B | $26.16B | $30.52B |
| Low | $24.94B | $26.16B | $30.52B |
| High | $24.94B | $26.16B | $30.52B |
| EBIT Avg | $17.38B | $18.23B | $21.27B |
| Low | $17.38B | $18.23B | $21.27B |
| High | $17.38B | $18.23B | $21.27B |
| Net Income Avg | $6.92B | $9.96B | $19.05B |
| Low | $6.92B | $9.96B | $19.05B |
| High | $6.92B | $9.96B | $19.05B |
| EPS Avg | $35.20 | $50.65 | $96.88 |
| Low | $35.20 | $50.65 | $96.88 |
| High | $35.20 | $50.65 | $96.88 |
| Analysts (Rev / EPS) | 3 / 1 | 2 / 1 | 1 / 1 |